Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Jazz Pharmaceuticals PLC    JAZZ   IE00B4Q5ZN47

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Jazz Pharmaceuticals PLC
Operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry.

Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd on January 18, 2012 and is headquartered in Dublin, Ireland.

Number of employees : 1 040 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Pharmaceutical Products1,325100%1,488100% +12.32%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States1,19390%1,35591.1% +13.58%
Europe103.617.8%106.157.1% +2.44%
Other28.312.1%26.911.8% -4.96%
Managers
NameAgeSinceTitle
Bruce C. Cozadd, MBA532012Chairman & Chief Executive Officer
Russell J. Cox542012Chief Operating Officer & Executive Vice President
Matthew P. Young, MBA482013Chief Financial Officer & Executive Vice President
Karen L. Smith MD, PhD492015Chief Medical Officer & EVP-Research & Development
Paul Treacy562014Senior Vice President-Technical Operations
Paul L. Berns502010Independent Director
Patrick G. Enright, MBA552012Independent Director
Seamus C. Mulligan562012Independent Director
Ken W. O'Keefe, MBA502012Independent Director
Rick E. Winningham, MBA572012Lead Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 60,064,963 58,658,827 97.7% 0 0.0% 97.7%
Shareholders
NameEquities%
Putnam Investment Management LLC 8,304,110 13.8%
Fidelity Management & Research Co. 8,178,680 13.6%
The Vanguard Group, Inc. 4,677,223 7.78%
BlackRock Fund Advisors 2,174,506 3.62%
Cadian Capital Management LP 1,392,575 2.32%
Westfield Capital Management Co. LP 1,323,264 2.20%
Renaissance Technologies LLC 1,201,500 2.00%
FIL Investment Advisors (UK) Ltd. 1,084,204 1.80%
Seamus C. Mulligan 1,049,373 1.75%
Senator Investment Group LP 1,000,000 1.66%
Company contact information
Jazz Pharmaceuticals Plc
Connaught House
One Burlington Road
4th Floor
Dublin 4

Phone : +353.1.634.7800
Fax : +353.1.634.7850
Web : www.jazzpharma.com
© 2017 People , Fundamentals and Ownership